Publications

2003

Magro CM, A Crowson N, Kovatich AJ, Burns F. Drug-induced reversible lymphoid dyscrasia: a clonal lymphomatoid dermatitis of memory and activated T cells. Hum Pathol. 2003;34(2):119-29.
Jang B-, Muñoz-Najar U, Paik J-, Claffey K, Yoshida M, Hla T. Leptomycin B, an inhibitor of the nuclear export receptor CRM1, inhibits COX-2 expression. J Biol Chem. 2003;278(5):2773-6.
Li Z, Pan L, Cesarman E, Knowles DM. Alterations of mRNA splicing in primary effusion lymphomas. Leuk Lymphoma. 2003;44(5):833-40.
Hinoi T, Loda M, Fearon ER. Silencing of CDX2 expression in colon cancer via a dominant repression pathway. J Biol Chem. 2003;278(45):44608-16.
Moscat J, Diaz-Meco MT. Par-4 keeps the atypical PKCs at bay. Cell Cycle. 2003;2(2):71-2.
Barbareschi M, Togni R, Aldovini D, Peterlini G, Dal Santo M, Sagramoso C, et al. [Tissue microarrays in oncology]. Pathologica. 2003;95(5):265-6.
Dadhania D, Muthukumar T, Ding R, Li B, Hartono C, Serur D, et al. Molecular signatures of urinary cells distinguish acute rejection of renal allografts from urinary tract infection. Transplantation. 2003;75(10):1752-4.
Li Y, Yu W-, Ren J, Chen W, Huang L, Kharbanda S, et al. Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein. Mol Cancer Res. 2003;1(10):765-75.
A Crowson N, Baschinsky DY, Kovatich A, Magro C. Granulomatous eccrinotropic lymphomatoid papulosis. Am J Clin Pathol. 2003;119(5):731-9.
Cong F, Zhang J, Pao W, Zhou P, Varmus H. A protein knockdown strategy to study the function of beta-catenin in tumorigenesis. BMC Mol Biol. 2003;4:10.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700